CardioGenics Holdings Inc Share Price

Equities

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 20:59:49 01/02/2024 GMT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for CardioGenics Holdings Inc -.--% -.--%
Sales 2014 - Sales 2015 - Capitalization 4.61M 367M
Net income 2014 -2M -159M Net income 2015 -1M -79.58M EV / Sales 2014 -
Net Debt 2014 132K 10.52M Net Debt 2015 157K 12.45M EV / Sales 2015 -
P/E ratio 2014
-2.3 x
P/E ratio 2015
-2.17 x
Employees 4
Yield 2014 *
-
Yield 2015
-
Free-Float 97.49%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.29
5 years
0.00
Extreme 0
0.29
10 years
0.00
Extreme 0
0.29
More quotes
Managers TitleAgeSince
Founder 66 19/11/97
Director of Finance/CFO 76 31/12/98
Director/Board Member 63 31/12/00
Members of the board TitleAgeSince
Chairman 74 31/12/02
Founder 66 19/11/97
Director/Board Member 63 31/12/00
More insiders
CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.
More about the company